Dieuwke Hooft Graafland
Senior Associate - Attorney at Law
Dieuwke Hooft Graafland-Dijkmans van Gunst, attorney at law, is a member of Loyens & Loeff's Healthcare Team since 2011.
Amsterdam
Dutch, English
Dieuwke is an expert in regulatory health law and works primarily for healthcare insurers and healthcare institutions. Dieuwke has extensive experience in proceedings and regularly represents clients in court on matters regarding healthcare insurance and healthcare financing law.
From a corporate law and regulatory point of view Dieuwke focuses on healthcare-related joint ventures, mergers and acquisitions and governance issues. Dieuwke is a regular speaker at seminars and events and a guest lecturer in the field of healthcare law at the Erasmus University Rotterdam. Dieuwke also worked in the Zürich (Switzerland) office (2017).
Work highlights
Contributions
Memberships
Amsterdam Bar Association
Dutch Association of Health Law
Dutch Health Care Compliance Association
Association of Young Litigation Lawyers
Qualifications
Post-doctoral in health law, Grotius Academy, Nijmegen, 2018 (with honors)
Master’s in Health Law, Erasmus Universiteit Rotterdam, 2011
Dieuwke Hooft Graafland
Senior Associate - Attorney at Law
dieuwke.hooftgraafland@loyensloeff.com
Amsterdam
Dutch, English
Dieuwke Hooft Graafland-Dijkmans van Gunst, attorney at law, is a member of Loyens & Loeff's Healthcare Team since 2011.
Dieuwke is an expert in regulatory health law and works primarily for healthcare insurers and healthcare institutions. Dieuwke has extensive experience in proceedings and regularly represents clients in court on matters regarding healthcare insurance and healthcare financing law.
From a corporate law and regulatory point of view Dieuwke focuses on healthcare-related joint ventures, mergers and acquisitions and governance issues. Dieuwke is a regular speaker at seminars and events and a guest lecturer in the field of healthcare law at the Erasmus University Rotterdam. Dieuwke also worked in the Zürich (Switzerland) office (2017).